Bernd R. Seizinger, Director of Aprea Therapeutics APRE, has filed 8 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $187.8K. The latest trade was on 06/16.

BS

BS

Bernd R. Seizinger

Director

Company

Aprea Therapeutics APRE

First filing

23/01/23

Trades

21 trades

Buys / sales

8 / 0

12-month net buying

$187.8K

Last trade

06/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Oncolytics BiotechONCY	Open-market buy	02/11–02/12	02/13	100,000 sh2 trades	$0.84avg.	$83,800	+21.4%
Oncolytics BiotechONCY	Open-market buy	01/16	01/20	100,000 sh	$1.04	$104,000	+27.2%
Aprea TherapeuticsAPRE	Open-market buy	24/10/11	24/10/15	10,000 sh	$2.68	$26,800	+28.8%
Aprea TherapeuticsAPRE	Open-market buy	24/03/13	24/03/14	6,860 sh	$7.29	$50,009.4	+25.6%
AB Aptose Biosciences	Open-market buy	23/09/22	23/09/25	17,000 sh	$3.14	$53,380	No record
Aprea TherapeuticsAPRE	Open-market buy	23/06/06–23/06/07	23/06/08	10,097 sh2 trades	$3.66avg.	$36,953.56	+62.2%